Day One Biopharmaceuticals Stock Price on June 7, 2024
| DAWN Stock | USD 13.72 0.18 1.33% |
If you're considering investing in Day Stock, it is important to understand the factors that can impact its price. As of today, the current price of Day One stands at 13.72, as last reported on the 29th of November, with the highest price reaching 13.78 and the lowest price hitting 13.50 during the day. As of now, Day Stock is not too volatile. Day One Biopharmaceu secures Sharpe Ratio (or Efficiency) of 0.0227, which denotes the company had a 0.0227% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Day One Biopharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Day One's Mean Deviation of 2.05, variance of 6.18, and Standard Deviation of 2.49 to check if the risk estimate we provide is consistent with the expected return of 0.0566%.
At this time, Day One's Total Stockholder Equity is very stable compared to the past year. As of the 29th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 394.9 M, while Common Stock Total Equity is likely to drop 5,985. . At this time, Day One's Price Book Value Ratio is very stable compared to the past year. As of the 29th of November 2024, Price To Book Ratio is likely to grow to 3.53, while Price Earnings Ratio is likely to drop (6.47). Day Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Day |
Sharpe Ratio = 0.0227
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | DAWN | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.5 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Day One is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Day One by adding it to a well-diversified portfolio.
Price Book 2.4909 | Enterprise Value Ebitda (7.18) | Price Sales 13.571 | Shares Float 69.4 M | Wall Street Target Price 37 |
Related Headline
Mereo BioPharma Headline on 7th of June 2024
Disposition of 5500 shares by Pakianathan Deepika of Mereo B... by Pakianathan Deepika
Filed transaction by Mereo BioPharma Group Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Day One Valuation on June 7, 2024
It is possible to determine the worth of Day One on a given historical date. On June 7, 2024 Day was worth 12.71 at the beginning of the trading date compared to the closed value of 12.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Day One stock. Still, in general, we apply an absolute valuation method to find Day One's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Day One where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Day One's related companies.
| Open | High | Low | Close | Volume | |
| 13.01 | 13.15 | 12.59 | 12.88 | 806,595 | |
06/07/2024 | 12.71 | 13.10 | 12.65 | 12.77 | 407,407 |
| 12.61 | 12.95 | 12.45 | 12.49 | 900,252 |
| Backtest Day One | | | Day One History | | | Day One Valuation | Previous | Next |
Day One Trading Date Momentum on June 7, 2024
| On June 10 2024 Day One Biopharmaceuticals was traded for 12.49 at the closing time. The top price for the day was 12.95 and the lowest listed price was 12.45 . The trading volume for the day was 900.3 K. The trading history from June 10, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.19% . The overall trading delta against the current closing price is 2.43% . |
Day One Biopharmaceu Fundamentals Correlations and Trends
By evaluating Day One's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Day One's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Day financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Day One Stock history
Day One investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Day is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Day One Biopharmaceu will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Day One stock prices may prove useful in developing a viable investing in Day One
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 79.8 M | 72.8 M | |
| Net Loss | -128 M | -134.4 M |
Day One Quarterly Net Working Capital |
|
Day One Stock Technical Analysis
Day One technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Day One Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Day One Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Day One November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Day One stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Day One shares will generate the highest return on investment. By undertsting and applying Day One stock market strength indicators, traders can identify Day One Biopharmaceuticals entry and exit signals to maximize returns
Day One Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Day One's price direction in advance. Along with the technical and fundamental analysis of Day Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Day to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0043 | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Day One Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Revenue Per Share 1.144 | Return On Assets (0.25) | Return On Equity (0.18) |
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.